Correlation Between Adaptimmune Therapeutics and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Inovio Pharmaceuticals.
Diversification Opportunities for Adaptimmune Therapeutics and Inovio Pharmaceuticals
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Adaptimmune and Inovio is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Inovio Pharmaceuticals
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 1.4 times more return on investment than Inovio Pharmaceuticals. However, Adaptimmune Therapeutics is 1.4 times more volatile than Inovio Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 107.00 in Adaptimmune Therapeutics Plc on September 1, 2024 and sell it today you would lose (35.00) from holding Adaptimmune Therapeutics Plc or give up 32.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Inovio Pharmaceuticals
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Inovio Pharmaceuticals |
Adaptimmune Therapeutics and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Inovio Pharmaceuticals
The main advantage of trading using opposite Adaptimmune Therapeutics and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.The idea behind Adaptimmune Therapeutics Plc and Inovio Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |